Clinical Trial

A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors

Name: A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors — clinical trial record (NCT07123129)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The main objective of this study is to evaluate the effectiveness and safety of SHR-7782 for participants with advanced malignant cancer.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-08-07; most recent amendment 2026-01-28.

Status change: Not Yet Recruiting → Recruiting 2025-09-19

Trial Details

NCT Number	NCT07123129
Lead Sponsor	Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions	Advanced Malignancy
Enrollment	200 participants
Start Date	2025-08-28
Primary Completion	2026-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-30